Immunofluorescence staining revealed that USP15 is mainly localized in the nuclei of PBMCs in healthy donors, but it existed in the cytoplasm of PBMCs and its expression level was obviously reduced in PBMCs of CML patients (Fig. 1 c). This evidence concerns the gene USP15 and chronic myelogenous leukemia, BCR-ABL1 positive.